TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.980
-0.030 (-0.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
TriSalus Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 16.48 | 11.78 | 9.41 | 30.3 | 4.49 |
Cash & Short-Term Investments | 16.48 | 11.78 | 9.41 | 30.3 | 4.49 |
Cash Growth | 322.16% | 25.10% | -68.93% | 575.16% | - |
Receivables | 4.71 | 3.55 | 1.56 | 1.36 | 0.62 |
Inventory | 3.44 | 2.55 | 1.47 | 1.29 | 0.57 |
Prepaid Expenses | 3.31 | 2.99 | 4.77 | 2.18 | - |
Other Current Assets | - | - | - | - | 0.41 |
Total Current Assets | 27.94 | 20.86 | 17.21 | 35.13 | 6.08 |
Property, Plant & Equipment | 2.95 | 3.27 | 3.61 | 1.8 | 1.26 |
Other Intangible Assets | 1.11 | 1.13 | 0.8 | 0.79 | 0.74 |
Other Long-Term Assets | 0.42 | 0.47 | 0.37 | 0.12 | 0.05 |
Total Assets | 32.43 | 25.73 | 22 | 37.84 | 8.13 |
Accounts Payable | 1.98 | 3.39 | 4.95 | 1.3 | 0.61 |
Accrued Expenses | 9.37 | 10.53 | 6.38 | 4.97 | 6.73 |
Current Portion of Long-Term Debt | - | - | - | - | 42.18 |
Current Portion of Leases | 0.32 | 0.35 | 0.37 | - | - |
Current Income Taxes Payable | 0.04 | 0.03 | - | - | - |
Other Current Liabilities | 0.29 | 0.39 | 20.66 | 0.1 | 5.22 |
Total Current Liabilities | 12 | 14.69 | 32.36 | 6.37 | 54.75 |
Long-Term Leases | 1.15 | 1.24 | 1.59 | - | - |
Other Long-Term Liabilities | 22.14 | 35.73 | 0.37 | 0.56 | 3.54 |
Total Liabilities | 56.58 | 51.66 | 34.32 | 6.93 | 58.29 |
Common Stock | 0 | 0 | - | 0.01 | 0.01 |
Additional Paid-In Capital | 241.78 | 222.44 | 10.03 | 6.73 | 1.36 |
Retained Earnings | -265.93 | -248.38 | -186.36 | -136.34 | -107.5 |
Total Common Equity | -24.15 | -25.94 | -176.33 | -129.6 | -106.13 |
Shareholders' Equity | -24.15 | -25.94 | -12.32 | 30.9 | -50.16 |
Total Liabilities & Equity | 32.43 | 25.73 | 22 | 37.84 | 8.13 |
Total Debt | 22.76 | 1.6 | 1.96 | - | 42.18 |
Net Cash (Debt) | -6.28 | 10.18 | 7.45 | 30.3 | -37.7 |
Net Cash Growth | - | 36.65% | -75.41% | - | - |
Net Cash Per Share | -0.30 | 1.08 | 24.07 | 3.42 | -4.91 |
Filing Date Shares Outstanding | 29.31 | 26.76 | 14.08 | 12.96 | 7.67 |
Total Common Shares Outstanding | 27.16 | 26.41 | 14.08 | 10.72 | 7.67 |
Working Capital | 15.94 | 6.18 | -15.14 | 28.76 | -48.67 |
Book Value Per Share | -0.89 | -0.98 | -12.53 | -12.09 | -13.83 |
Tangible Book Value | -25.26 | -27.07 | -177.13 | -130.4 | -106.87 |
Tangible Book Value Per Share | -0.93 | -1.02 | -12.58 | -12.16 | -13.93 |
Machinery | - | 4.4 | 3.87 | 3.15 | 2.36 |
Leasehold Improvements | - | 0.77 | 0.77 | 0.78 | 0.68 |
Source: S&P Capital IQ. Standard template. Financial Sources.